Buy Alembic Pharmaceuticals, price target Rs 698: Dharmesh Shah

The analyst suggested a stoploss at Rs 630.

Shutterstock.com
Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 12427.91 Crore) operating in Pharmaceuticals sector.
Dharmesh Shah of ICICI Direct has a buy call on Alembic Pharmaceuticals Ltd. with a target price of Rs 698.0 . The current price of Alembic Pharmaceuticals Ltd. is Rs 659.25 . Dharmesh Shah recommended to keep a stoploss at Rs 630 .

Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 12427.91 Crore) operating in Pharmaceuticals sector.

Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 3533.84 Crore to Sales Value (96.54 % of Total Sales), Export Incentives which contributed Rs 88.18 Crore to Sales Value (2.40 % of Total Sales), Royalty Income which contributed Rs 30.67 Crore to Sales Value (0.83 % of Total Sales) and Other Operating Revenue which contributed Rs 7.58 Crore to Sales Value (0.20 % of Total Sales)for the year ending 31-Mar-2019.


For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 1209.13 Crore, down -2.56 % from last quarter Sales of Rs 1240.87 Crore and up 18.76 % from last year same quarter Sales of Rs 1018.15 Crore Company has reported net profit after tax of Rs 227.68 Crore in latest quarter.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Alembic Pharmaceuticals, price target Rs 698: Dharmesh Shah
Text Size:AAA
Success
This article has been saved

*

+